Study

EORTC-1942-QLG-GUCG

The need for validated Bladder Cancer Modules: Update and potential merging of the existing MIBC and the NMIBC modules – including an assessment focused on metastatic bladder cancer

Study documentation Back to result

Trial Status

Recruiting

Dates

Data management at EORTC

None

Design

QoL Module development
Not randomized / N.A.

Study Staff

  • Mieke Van Hemelrijck (Study Coordinator), Guy s and St Thomas' NHS - Guy's Hospital, London
  • Valerie Fonteyne (Study Co-Coordinator), Universitair Ziekenhuis Gent, Gent
  • Marieke Van Leeuwen (Study Co-Coordinator), The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
  • Corneel Coens (Statistician), EORTC Headquarters, Brussels
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Elke Rammant (Fellow), Universitair Ziekenhuis Gent, Gent
  • Francesca Martinelli (QoL Specialist), EORTC Headquarters, Brussels
  • Madeline Pe (QoL Specialist), EORTC Headquarters, Brussels

Type of cancer

  • Bladder

Participating groups

  • EORTC Genito-Urinary Cancers Group
  • EORTC Quality of Life Group